Form 8-K · Current report
Philip Morris International 8-K, filed Oct 21, 2026
- Filed
- CIK
- 0001413329
- Accession no.
- 0001628280-26-066596
Summary
Philip Morris International reported third-quarter 2026 net revenues up 5.5% to $11.4 billion and adjusted diluted EPS of $2.36, up 5.4%, while reported diluted EPS fell 4.9% to $2.12 on a non-cash fair value adjustment to equity security investments. It updated its 2026 full-year adjusted diluted EPS forecast for currency only and raised its quarterly dividend 8.8% to $1.60 per share.
Key points
- Third-quarter 2026 shipments rose 0.6%, with smoke-free products up 2.7% and VEEV e-vapor shipments up 61.6%.
- U.S. ZYN shipments grew 4.2% to 3.2 billion pouches, and the FDA granted PMTA authorization to 11 ZYN ULTRA variants on August 21, bringing ZYN to 31 authorized variants.
- IQOS heated-tobacco units rose 1.5% to 41.5 billion units, with PMI holding about three-quarters of global HTU volume share.
- Smoke-free products accounted for more than 40% of third-quarter net revenues and are sold in 110 markets.
Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.
Items reported
- 2.02Results of Operations and Financial Condition
- 9.01Financial Statements and Exhibits
From the filing
Item 2.02. Results of Operations and Financial Condition. On October 21, 2026, Philip Morris International Inc. (the “Company”) issued a press release announcing its financial results for the third quarter and the nine months ended September 30, 2026, as well as the accompanying glossary of key terms, definitions, explanatory notes, select financial information and reconciliations of non-GAAP financial measures. The earnings release is attached as Exhibit 99.1 to this Current Report on Form 8-K and incorporated by reference to this Item 2.02. …
An excerpt of the text as filed with the SEC, cut for length.
Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.